+44 (0) 1698 534002
Contact
About Us
About BioAscent
Company Video
Board
Management Team
Scientific Team
Awards
Testimonials
Our Values
Our Site
Read more
Integrated Drug Discovery
Integrated Drug Discovery
Overview
Integrated Drug Discovery Projects
Biology
Biochemical, Biophysical & Cellular Assay Development
Target Analysis & Bespoke Screening Strategies
Compound Screening
In Silico Discovery and Data Analysis
In Silico Discovery and Data Analysis
Accelerating CNS Drug Discovery
Chemistry
Medicinal Chemistry
Synthetic Chemistry
Physicochemical Profiling & DMPK
Protein Science and Structural Biology
Protein Production
Surface Plasmon Resonance (SPR) & Biophysics
Target Classes and Indications
Mitochondrial Biology
GPCR Drug Discovery
CNS Drug Discovery
Compound Libraries
In-house Diversity, Fragment & Chemogenomic Libraries
External Library Selection & Sourcing
Compound Management
Resources
Blog
Case Studies
Publications
Posters
News & Events
News
Events
Careers
About Us
- About BioAscent
- Company Video
- Board
- Management Team
- Scientific Team
- Awards
- Testimonials
- Our Values
Integrated Drug Discovery
- Overview
- Integrated Drug Discovery Projects
- Biochemical, Biophysical & Cellular Assay Development
- Target Analysis & Bespoke Screening Strategies
- Compound Screening
- In Silico Discovery and Data Analysis
- Accelerating CNS Drug Discovery
- Medicinal Chemistry
- Synthetic Chemistry
- Physicochemical Profiling & DMPK
- Protein Production
- Surface Plasmon Resonance (SPR) & Biophysics
- Mitochondrial Biology
- GPCR Drug Discovery
- CNS Drug Discovery
- In-house Diversity, Fragment & Chemogenomic Libraries
- External Library Selection & Sourcing
Compound Management
Resources
- Blog
- Case Studies
- Publications
- Posters
News & Events
- News
- Events
Careers
Case Studies
Managing a 250K screening library for a drug discovery customer
Read case study
Lead generation: discovery of novel KLK6 Inhibitors as novel anti-cancer drugs
Read case study
Setting the trajectory for success - discovery of novel broad-spectrum metallo-β-lactamase Inhibitors
Read case study
Pooling and plating 85,000 compounds for a drug discovery customer
Read case study
Sourcing, aggregating, plating and shipping a custom 144k screening library for a virtual drug discovery customer
Read case study
Using BioAscent's compound management services to accelerate design-make-test cycles
Read case study
Integrated Drug Discovery
Science-led drug discovery
Compound Management
Connecting and accelerating your drug discovery
Medicinal Chemistry
Proven expertise in design and synthesis
In Silico Discovery
Accelerating drug design with computational expertise
Discovery Biology
Screening expertise across target classes
Get in Touch
Let's talk about how we can maximise your drug discovery success.
Contact